Header

UZH-Logo

Maintenance Infos

Browse by Creators

Navigate back| Up a level
Export as
Number of items: 4.

Engert, A; Haverkamp, H; Kobe, C; Markova, J; Renner, C; Ho, A; Zijlstra, J; Král, Z; Fuchs, M; Hallek, M; Kanz, L; Döhner, H; Dörken, B; Engel, N; Topp, M; Klutmann, S; Amthauer, H; Bockisch, A; Kluge, R; Kratochwil, C; Schober, O; Greil, R; Andreesen, R; Kneba, M; Pfreundschuh, M; Stein, H; Eich, H T; Müller, R P; Dietlein, M; Borchmann, P; Diehl, V (2012). Reduced-intensity chemotherapy and PET-guided radiotherapy in patients with advanced stage Hodgkin's lymphoma (HD15 trial): a randomised, open-label, phase 3 non-inferiority trial. Lancet, 379(9828):1791-1799.

Patrij, K; Reiser, M; Wätzel, L; Pels, H; Kowoll, A; Herrlinger, U; Engert, A; Linnebank, M; Schackert, G; Vogt-Schaden, M; Egerer, G; Lamprecht, M; Batchelor, T T; Schlegel, U; Schmidt-Wolf, I G H (2011). Isolated central nervous system relapse of systemic lymphoma (SCNSL): clinical features and outcome of a retrospective analysis. German Medical Science, 9:Doc11.

Juergens, A; Pels, H; Rogowski, S; Fliessbach, K; Glasmacher, A; Engert, A; Reiser, M; Diehl, V; Vogt-Schaden, M; Egerer, G; Schackert, G; Reichmann, H; Kroschinsky, F; Bode, U; Herrlinger, U; Linnebank, M; Deckert, M; Fimmers, R; Schmidt-Wolf, I G H; Schlegel, U (2010). Long-term survival with favorable cognitive outcome after chemotherapy in primary central nervous system lymphoma. Annals of Neurology, 67(2):182-189.

Pels, H; Juergens, A; Glasmacher, A; Schulz, H; Engert, A; Linnebank, M; Schackert, G; Reichmann, H; Kroschinsky, F; Vogt-Schaden, M; Egerer, G; Bode, U; Schaller, C; Lamprecht, M; Hau, P; Deckert, M; Fimmers, R; Bangard, C; Schmidt-Wolf, G; Schlegel, U (2009). Early relapses in primary CNS lymphoma after response to polychemotherapy without intraventricular treatment: results of a phase II study. Journal of Neuro-Oncology, 91(3):299-305.

This list was generated on Sun Dec 17 22:12:43 2017 CET.